[Narcotic analgesics. Part IV. Agonists-antagonists and total antagonists of opiate receptors. Perspectives for clinical use of narcotic analgesics].
Dubitskiĭ
A E
AE
Beliaev
A V
AV
Ryzhiĭ
S M
SM
Volikovskaia
E V
EV
Butylin
V Iu
VIu
Davydov
N Iu
NIu
D000701:Analgesics, Opioid / Q000627:therapeutic use*; D002077:Butorphanol / Q000627:therapeutic use; D006801:Humans; D009266:Nalbuphine / Q000627:therapeutic use; D009269:Nalorphine / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists; D010166:Palliative Care; D010423:Pentazocine / Q000627:therapeutic use; D011379:Prognosis
D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D009270:Naloxone; D009266:Nalbuphine; D002077:Butorphanol; D010423:Pentazocine; D009269:Nalorphine